REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 10th, 2021 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February __, 2021, between Silo Pharma, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 10th, 2021 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February __, 2021 between Silo Pharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT SILO pharma, inc.Security Agreement • February 10th, 2021 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ___________ (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February __, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LOCK-UP AGREEMENTLock-Up Agreement • February 10th, 2021 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
Re: Securities Purchase Agreement, dated as of February __, 2021 (the “Purchase Agreement”), between Silo Pharma, Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”)
